Our elucidation of the critical impact of ADAM15 on the orchestration of mechanoinflammation in SF suggests its potential as a target for therapeutic intervention, which is supported by data on the amelioration of murine collagen-induced arthritis through treatment with ADAM15-specific siRNA [64]. This evidence concerns the gene ADAM15 and arthritic joint disease.